Manganese Sulfate Nanocomposites Fabricated by Hot-Melt Extrusion for Chemodynamic Therapy of Colorectal Cancer
The development of metal salts-based nanocomposites is highly desired for the Fenton or Fenton-like reaction-based chemodynamic therapy of cancer. Manganese sulfate (MnSO<sub>4</sub>)-dispersed nanoparticles (NPs) were fabricated with a hot-melt extrusion (HME) system for the chemodynami...
Saved in:
Main Authors: | , , , , , , , , , , , |
---|---|
Format: | Book |
Published: |
MDPI AG,
2023-06-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | The development of metal salts-based nanocomposites is highly desired for the Fenton or Fenton-like reaction-based chemodynamic therapy of cancer. Manganese sulfate (MnSO<sub>4</sub>)-dispersed nanoparticles (NPs) were fabricated with a hot-melt extrusion (HME) system for the chemodynamic therapy of colorectal cancer in this study. MnSO<sub>4</sub> was homogeneously distributed in polyethylene glycol (PEG) 6000 (as a hydrophilic polymer) with the aid of surfactants (Span 80 and Tween 80) by HME processing. Nano-size distribution was achieved after dispersing the pulverized extrudate of MnSO<sub>4</sub>-based composite in the aqueous media. The distribution of MnSO<sub>4</sub> in HME extrudate and the interactions between MnSO<sub>4</sub> and pharmaceutical additives were elucidated by Fourier-transform infrared, X-ray diffractometry, X-ray photoelectron spectroscopy, and scanning electron microscopy analyses. Hydroxyl radical generation efficiency by the Fenton-like chemistry capability of Mn<sup>2+</sup> ion was also confirmed by catalytic assays. By using the intrinsic H<sub>2</sub>O<sub>2</sub> in cancer cells, MnSO<sub>4</sub> NPs provided an elevated cellular reactive oxygen species level, apoptosis induction capability, and antiproliferation efficiency. The designed HME-processed MnSO<sub>4</sub> formulation can be efficiently used for the chemodynamic therapy of colorectal cancer. |
---|---|
Item Description: | 10.3390/pharmaceutics15071831 1999-4923 |